Your browser doesn't support javascript.
loading
Reducing overdose deaths among persons with opioid use disorder in connecticut.
Scheidell, Joy D; Townsend, Tarlise N; Zhou, Qinlian; Manandhar-Sasaki, Prima; Rodriguez-Santana, Ramon; Jenkins, Mark; Buchelli, Marianne; Charles, Dyanna L; Frechette, Jillian M; Su, Jasmine I-Shin; Braithwaite, R Scott.
  • Scheidell JD; Department of Health Sciences, University of Central Florida, PO Box 160000, Orlando, FL, 32816, USA. Joy.Scheidell@ucf.edu.
  • Townsend TN; Department of Population Health, New York University Grossman School of Medicine, 227 E. 30th St, New York, NY, 10016, USA.
  • Zhou Q; Center for Opioid Epidemiology and Policy, New York University Grossman School of Medicine, New York, NY, USA.
  • Manandhar-Sasaki P; Department of Population Health, New York University Grossman School of Medicine, 227 E. 30th St, New York, NY, 10016, USA.
  • Rodriguez-Santana R; Department of Population Health, New York University Grossman School of Medicine, 227 E. 30th St, New York, NY, 10016, USA.
  • Jenkins M; HIV Prevention Program, Connecticut Department of Public Health, 410 Capitol Avenue, MS #11APV, Hartford, CT, 06134-0308, USA.
  • Buchelli M; Connecticut Harm Reduction Alliance, 28 Grand St, Hartford, CT, 06106, USA.
  • Charles DL; HIV Prevention Program, Connecticut Department of Public Health, 410 Capitol Avenue, MS #11APV, Hartford, CT, 06134-0308, USA.
  • Frechette JM; TB, HIV, STD and Viral Hepatitis Section, Connecticut Department of Public Health, 410 Capitol Avenue, MS #11APV, Hartford, CT, 06134, USA.
  • Su JI; Department of Population Health, New York University Grossman School of Medicine, 227 E. 30th St, New York, NY, 10016, USA.
  • Braithwaite RS; Department of Population Health, New York University Grossman School of Medicine, 227 E. 30th St, New York, NY, 10016, USA.
Harm Reduct J ; 21(1): 103, 2024 May 28.
Article en En | MEDLINE | ID: mdl-38807226
ABSTRACT

BACKGROUND:

People in Connecticut are now more likely to die of a drug-related overdose than a traffic accident. While Connecticut has had some success in slowing the rise in overdose death rates, substantial additional progress is necessary.

METHODS:

We developed, verified, and calibrated a mechanistic simulation of alternative overdose prevention policy options, including scaling up naloxone (NLX) distribution in the community and medications for opioid use disorder (OUD) among people who are incarcerated (MOUD-INC) and in the community (MOUD-COM) in a simulated cohort of people with OUD in Connecticut. We estimated how maximally scaling up each option individually and in combinations would impact 5-year overdose deaths, life-years, and quality-adjusted life-years. All costs were assessed in 2021 USD, employing a health sector perspective in base-case analyses and a societal perspective in sensitivity analyses, using a 3% discount rate and 5-year and lifetime time horizons.

RESULTS:

Maximally scaling NLX alone reduces overdose deaths 20% in the next 5 years at a favorable incremental cost-effectiveness ratio (ICER); if injectable rather than intranasal NLX was distributed, 240 additional overdose deaths could be prevented. Maximally scaling MOUD-COM and MOUD-INC alone reduce overdose deaths by 14% and 6% respectively at favorable ICERS. Considering all permutations of scaling up policies, scaling NLX and MOUD-COM together is the cost-effective choice, reducing overdose deaths 32% at ICER $19,000/QALY. In sensitivity analyses using a societal perspective, all policy options were cost saving and overdose deaths reduced 33% over 5 years while saving society $338,000 per capita over the simulated cohort lifetime.

CONCLUSIONS:

Maximally scaling access to naloxone and MOUD in the community can reduce 5-year overdose deaths by 32% among people with OUD in Connecticut under realistic budget scenarios. If societal cost savings due to increased productivity and reduced crime costs are considered, one-third of overdose deaths can be reduced by maximally scaling all three policy options, while saving money.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Sobredosis de Droga / Naloxona / Antagonistas de Narcóticos / Trastornos Relacionados con Opioides Límite: Adult / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Sobredosis de Droga / Naloxona / Antagonistas de Narcóticos / Trastornos Relacionados con Opioides Límite: Adult / Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2024 Tipo del documento: Article